Safety Evaluation of Dexmedetomidine for EBUS-TBNA (EBUSed)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01381627|
Recruitment Status : Unknown
Verified June 2011 by Louis-Philippe Fortier, Maisonneuve-Rosemont Hospital.
Recruitment status was: Recruiting
First Posted : June 27, 2011
Last Update Posted : February 28, 2013
Information provided by (Responsible Party):
Louis-Philippe Fortier, Maisonneuve-Rosemont Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||June 2013|
|Estimated Study Completion Date :||June 2013|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
St-Pierre P, Tanoubi I, Verdonck O, Fortier LP, Richebé P, Côté I, Loubert C, Drolet P. Dexmedetomidine Versus Remifentanil for Monitored Anesthesia Care During Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: A Randomized Controlled Trial. Anesth Analg. 2019 Jan;128(1):98-106. doi: 10.1213/ANE.0000000000003633.